Immunogene Therapy of Recurrent Glioblastoma Multiforme with a Liposomally Encapsulated Replication-Incompetent Semliki Forest Virus Vector Carrying the Human Interleukin-12 Gene – A Phase I/II Clinical Protocol (original) (raw)
References
Black PM: Surgery for cerebral gliomas: past, present, and future. Clin Neurosurg 47: 21–45, 2000 Google Scholar
Salford LG, Brun A, Nirfalk S: Ten-year survival among patients with supratentorial astrocytomas grade III and IV. J Neurosurg 69: 506–509, 1988 Google Scholar
Shapiro WR: Therapy of adult malignant brain tumors: what have the clinical trials taught us? Semin Oncol 13: 38–45, 1986 Google Scholar
Ammirati M, Galicich JH, Arbit E, Liao Y: Reoperation in the treatment of recurrent intracranial malignant gliomas. Neurosurgery 21: 607–614, 1987 Google Scholar
Rajan B, Ross G, Lim CC, Ashley S, Goode D, Traish D, Brada M: Survival in patients with recurrent glioma as a measure of treatment efficacy: prognostic factors following nitrosourea chemotherapy. Eur J Cancer 12: 1809–1815, 1994 Google Scholar
Mach N, Dranoff G: Cytokine-secreting tumor cell vaccines. Curr Opin Immunol 12: 571–575, 2000 Google Scholar
Niranjan A, Moriuchi S, Lunsford LD, Kondziolka D, Flickinger JC, Fellows W, Rajendiran S, Tamura M, Cohen JB, Glorioso JC: Effective treatment of experimental glioblastoma by HSV vector-mediated TNF alpha and HSV-tk gene transfer in combination with radiosurgery and ganciclovir administration. Mol Ther 2: 114–120, 2000 Google Scholar
Mackensen A, Lindemann A, Mertelsmann R: Immunostimulatory cytokines in somatic cells and gene therapy of cancer. Cytokine Growth Factor Rev 8: 119–128, 1997 Google Scholar
Qian HN, Liu GZ, Cao SJ, Feng J, Ye X: Experimental study of ovarian carcinoma vaccine modified by human B7-1 and IFN-gamma genes. Int J Gynecol Cancer 12: 80–85, 2002 Google Scholar
Boulikas T: Status of gene therapy in 1997: molecular mechanisms, disease targets, and clinical applications. Gene Ther Mol Biol 1: 1–172, 1998 Google Scholar
Wigginton JM, Gruys E, Geiselhart L, Subleski J, Komschlies KL, Park JW, Wiltrout TA, Nagashima K, Back TC, Wiltrout RH: IFN-gamma and Fas/FasL are required for the antitumor and antiangiogenic effects of IL-12/pulse IL-2 therapy. J Clin Invest 108: 51–62, 2001 Google Scholar
Colombo MP, Trinchieri G: Interleukin-12 in anti-tumor immunity and immunotherapy. Cytokine Growth Factor Rev 13: 155–168, 2002 Google Scholar
Liu Y, Ehtesham M, Samoto K, Wheeler CJ, Thompson RC, Villarreal LP, Black KL, Yu JS: In situ adenoviral interleukin 12 gene transfer confers potent and long-lasting cytotoxic immunity in glioma. Cancer Gene Ther 9: 9–15, 2002 Google Scholar
Trinchieri G, Scott P: Interleukin-12: basic principles and clinical applications. Curr Top Microbiol Immunol 238: 57–78, 1999 Google Scholar
Asselin-Paturel C, Lassau N, Guinebretiere JM, Zhang J, Gay F, Bex F, Hallez S, Leclere J, Peronneau P, Mami-Chouaib F, Chouaib S: Transfer of the murine interleukin-12 gene in vivo by a Semliki forest virus vector induces B16 tumor regression through inhibition of tumor blood vessel formation monitored by Doppler ultrasonography. Gene Ther 6: 606–615, 1999 Google Scholar
Wolf SF, Lee K, Swiniarski H, O'Toole M, Sturmhoefel K: Cytokines and cancer immunotherapy. Immunol Invest 29: 143–146, 2000 Google Scholar
Hiscox S, Jiang WG: Regulation of endothelial CD44 expression and endothelium-tumour cell interactions by hepatocyte growth factor/scatter factor. Biochem Biophys Res Commun 233: 1–5, 1997 Google Scholar
Salgaller ML, Lodge PA: Use of cellular and cytokine adjuvants in the immunotherapy of cancer. J Surg Oncol 68: 122–138, 1998 Google Scholar
Smyth MJ, Godfrey DI, Trapani JA: A fresh look at tumor immunosurveillance and immunotherapy. Nat Immunol 2: 293–299, 2001 Google Scholar
Yamanaka R, Zullo SA, Tanaka R, et al.: Induction of a therapic antitumor immunological response by intratumoral injection of genetically engineered Semliki forest virus to produce IL-12. Neurosurg Focus 9: 1–6, 2000 Google Scholar
Lundstrom K, Schweitzer C, Richards JG, Ehrengruber MU, Jenck F,Mülhardt C: Semliki forest virus vectors for in vitro and in vivo applications. Gene Ther Mol Biol 4: 23–31, 1999 Google Scholar
Lundstrom K: Novel developments for applications of alphavirus vectors in gene therapy. Gene Ther Mol Biol 6: 25–31, 2001 Google Scholar
Lundstrom K: Alphavirus vectors: applications for DNA vaccine production and gene expression. Intervirology 43: 247–257, 2000 Google Scholar
Hardy PA, Mazzini MJ, Schweitzer C, Lundstrom K, Glode LM: Recombinant Semliki forest virus infects and kills human prostate cancer cell lines and prostatic duct epithelial cells ex vivo. Int J Mol Med 5: 241–245, 2000 Google Scholar
Murphy A-M, Morris-Downes MM, Sheahan BJ, Atkins GJ: Inhibition of human lung carcinoma cell growth by apoptosis induction using Semliki forest virus recombinant particles. Gene Ther 7: 1477–1482, 2000 Google Scholar
Lundstrom K, Richards JG, Pink JR, Jenck F: Efficient in vivo expression of a reporter gene in rat brain after injection of recombinant replication-deficient Semliki forest virus. Gene Ther Mol Biol 3: 15–23, 1999 Google Scholar
Yamanaka R, Zullo SA, Tanaka R, Blaese M, Xanthopoulos KG: Enhancement of antitumor immune response in glioma models in mice by genetically modified dendritic cells pulsed with Semliki forest virus-mediated complementary DNA. J Neurosurg 94: 474–481, 2001 Google Scholar
Colmenero P, Liljeström P, Jondal M: Induction of P185 tumor immunity by recombinant Semliki forest virus expressing the P1A gene. Gene Ther 6: 1728–1733, 1999 Google Scholar
Ying H, Zaks TZ, Wang RF, Irvine KR, Kammula US, Marincola FM, Leitner WW, Restifo NP: Cancer therapy using a self-replicating RNA vaccine. Nat Med 5: 823–827, 1999 Google Scholar
Daemen T, Pries F, Bungener L, Kraak M, Regts J, Wilschut J: Genetic immunization against cervical carcinoma: induction of cytotoxic T lymphocyte activity with a recombinant alphavirus vector expressing human papillomavirus type 16 E6 and E7. Gene Ther 7: 1859–1866, 2000 Google Scholar
Atkins GJ, Sheahan BJ, Liljestrom P: Manipulation of the Semliki forest virus genome and its potential for vaccine construction. Mol Biotechnol 5: 33–38, 1996 Google Scholar
Martin F, Boulikas T: The challenge of liposomes in gene therapy. Gene Ther Mol Biol 1: 173–214, 1998 Google Scholar